Sign in

    Brent Geikie

    Research Analyst at Private Investor

    Brent Geikie is an analyst at Private Investor, specializing in providing research and analysis for private investment opportunities. While detailed public performance metrics and specific companies covered are not available, Geikie focuses on market trends and investment strategies aimed at maximizing client returns. His career includes experience in financial analysis, though verified information on previous firms, career start date, or professional credentials such as FINRA registration or securities licenses is not currently accessible. He is recognized for his thoughtful approach to private investment research and client engagement.

    Brent Geikie's questions to IGXT leadership

    Brent Geikie's questions to IGXT leadership • Q3 2023

    Question

    Inquired about the status and revenue timeline for the first CDMO contract, the potential for a second CDMO deal, and the pricing of atai's share purchase. He later followed up asking about potential communications from Tilray and if atai might buy shares on the open market.

    Answer

    The CDMO deal is a binding term sheet, with a definitive agreement expected in Q1 2024 and revenue in late 2024/early 2025. No second deal is on the immediate horizon. Atai's investment price is fixed at $0.185 per the convertible note. Tilray is unlikely to issue a press release until they have the product. Atai is not expected to buy shares on the open market but can provide support via existing warrants and notes.

    Ask Fintool Equity Research AI